Drugs 2012-12-05 SFDA requirements for labeling and Packaging for investigational medicinal products (IMP) View
Drugs Circular suspension of registration preparations extended to the people of long-term aerobic View
Drugs Circulated to all pharmaceutical companies need to send periodic reports to the updated drug safety (PSUR) for marketed drugs View